BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Angi Inc
ANGI
$176M
| $18.5K | ﹤0.01% |
261
+59
| +29% | +$6.05K |
|
3852
Coastal Financial
CCB
$754M
| $18.4K | ﹤0.01% |
1,221
+261
| +27% | +$3.97K |
|
3853
Biglari Holdings Class B
BH
$1.23B
| $18.4K | ﹤0.01% |
169
+46
| +37% | +$4.55K |
|
3854
Franco-Nevada
FNV
$45.5B
| $18.2K | ﹤0.01% |
200
| – | – |
|
3855
LSB Industries
LXU
$711M
| $18.2K | ﹤0.01% |
4,564
-362
| -7% | -$1.29K |
|
3856
Energous
WATT
$93.4M
| $18.2K | ﹤0.01% |
9
+2
| +29% | +$4.66K |
|
|
PYX
3857
DELISTED
Pyxus International, Inc.
PYX
| $18.1K | ﹤0.01% |
1,385
-501
| -27% | -$7.24K |
|
3858
Aldeyra Therapeutics
ALDX
$91.7M
| $18.1K | ﹤0.01% |
3,434
+856
| +33% | +$4.61K |
|
3859
Ocular Therapeutix
OCUL
$2.25B
| $18K | ﹤0.01% |
5,935
+1,862
| +46% | +$8.32K |
|
|
CMRX
3860
DELISTED
Chimerix, Inc.
CMRX
| $18K | ﹤0.01% |
7,669
+137
| +2% | +$396 |
|
|
MFNC
3861
DELISTED
Mackinac Financial Corporation
MFNC
| $18K | ﹤0.01% |
1,165
+721
| +162% | +$10.9K |
|
3862
Kinetik
KNTK
$4.12B
| $18K | ﹤0.01% |
636
+623
| +4,792% | +$18.7K |
|
3863
Suburban Propane Partners
SPH
$1.18B
| $18K | ﹤0.01% |
760
-470
| -38% | -$11.1K |
|
|
TYME
3864
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $17.9K | ﹤0.01% |
15,036
+2,827
| +23% | +$3.56K |
|
3865
Lennar Class B
LEN.B
$20.1B
| $17.9K | ﹤0.01% |
424
+143
| +51% | +$5.44K |
|
|
GBL
3866
DELISTED
GAMCO Investors, Inc.
GBL
| $17.9K | ﹤0.01% |
914
+256
| +39% | +$4.91K |
|
3867
Frontline
FRO
$8.81B
| $17.8K | ﹤0.01% |
1,951
-6,694
| -77% | -$54K |
|
|
PRGX
3868
DELISTED
PRGX Global, Inc.
PRGX
| $17.7K | ﹤0.01% |
3,445
+995
| +41% | +$5.75K |
|
|
RNET
3869
DELISTED
RigNet, Inc.
RNET
| $17.7K | ﹤0.01% |
2,281
+700
| +44% | +$5.9K |
|
3870
Flexsteel Industries
FLXS
$301M
| $17.6K | ﹤0.01% |
1,190
+12
| +1% | +$196 |
|
|
TEUM
3871
DELISTED
Pareteum Corporation
TEUM
| $17.6K | ﹤0.01% |
13,654
+10,667
| +357% | +$28K |
|
3872
Anavex Life Sciences
AVXL
$316M
| $17.6K | ﹤0.01% |
5,572
+4,073
| +272% | +$11.8K |
|
3873
Marker Therapeutics
MRKR
$19.3M
| $17.6K | ﹤0.01% |
344
+337
| +4,814% | +$19.9K |
|
3874
Hamilton Beach Brands
HBB
$443M
| $17.5K | ﹤0.01% |
1,085
+331
| +44% | +$5.12K |
|
|
USX
3875
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $17.5K | ﹤0.01% |
3,631
-18
| -0.5% | -$82 |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.